NCT01504841: A reported trial by National Institute of Allergy and Infectious Diseases (NIAID)
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT01504841 |
|---|---|
| Title | A Phase I/II, Open-Label Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of Etravirine (ETR) in Antiretroviral (ARV) Treatment-Experienced HIV-1 Infected Infants and Children, Aged ≥ 2 Months to < 6 Years |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | March 14, 2013 |
| Completion date | July 17, 2018 |
| Required reporting date | July 17, 2019, midnight |
| Actual reporting date | July 16, 2019 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |